Peptides in perimenopause and menopause: a hormones-first approach

What is actually changing

Perimenopause can last several years. Estrogen and progesterone rise and fall unpredictably before settling at lower levels after menopause. Those swings drive hot flashes, night sweats and sleep disruption, and they affect mood, joint comfort, vaginal health and where the body stores fat. Bone loss speeds up in the years around the final period.

Many of the symptoms women hope a peptide will fix, such as poor sleep, low energy and weight change around the middle, trace back to these hormone shifts. That is why the first conversation is usually about menopause care itself.

Hormone therapy comes first

Hormone therapy is the most effective treatment for hot flashes and night sweats, treats vaginal dryness and helps prevent bone loss. For most healthy women, benefits are most favorable when it is started before 60 or within 10 years of menopause. If you have a uterus, estrogen is paired with progesterone to protect the uterine lining.

No peptide replaces hormone therapy or has been shown to relieve hot flashes. If hormone therapy is not right for you, there are also non-hormonal prescription options worth discussing with your clinician.

Where peptides may be considered

Once menopause symptoms are being addressed, some women want to look at sleep quality, recovery from exercise or energy. A clinician may discuss:

• Sermorelin (from $199/month): a growth hormone–releasing hormone analog. A sermorelin product was once FDA-approved and later discontinued for reasons the FDA found were not related to safety or effectiveness. Compounded sermorelin is not FDA-approved, and evidence for its use in midlife women is limited.
• NAD+ injection (from $199/month): explored for energy. Human evidence for benefits is early and mixed, and compounded NAD+ is not FDA-approved.

An honest look at the evidence

Research on wellness peptides in women in midlife is sparse. Most studies are small, short, conducted in men or animals, or not designed to answer the questions women are asking. We will not tell you a peptide will reverse menopause weight gain or restore energy, because the evidence does not show that.

If you try one, it should be with a defined goal and time frame, and stopped if it does not help.

Weight changes in menopause

Weight gain around the middle during the menopause transition reflects hormone changes, muscle loss, sleep disruption and changes in activity. Strength training, adequate protein and sleep help. For women who meet the criteria, GLP-1 medication may be an option, and GLP-1s themselves are peptides. Compounded semaglutide and tirzepatide are not FDA-approved and are not the same as branded products.

Safety points for women

• Peptides are not for use during pregnancy or breastfeeding, and perimenopausal women can still become pregnant.
• Women with a history of breast cancer or other hormone-sensitive cancer should discuss any growth hormone–related therapy with their oncologist.
• New or unusual bleeding in perimenopause or after menopause should be evaluated, not attributed to a supplement or peptide.
• Compounded peptides are not FDA-approved; ask which pharmacy prepares yours.

Sleep in the menopause transition

Sleep problems in midlife women have several sources: night sweats, anxiety, a need to urinate at night and, increasingly after menopause, sleep apnea, which is often missed in women. Hormone therapy can reduce night sweats, and cognitive behavioral therapy for insomnia has strong evidence. These are usually more effective first steps than a peptide marketed for sleep.

How we approach it

You start with the free eligibility check and a review of your symptoms, cycle history and health history. Labs are ordered when they help, for example thyroid, iron and metabolic markers when symptoms overlap. Your clinician will usually address menopause symptoms first, then revisit whether a peptide is still worth trying.